The Cooper Companies, Inc.
COO
Clasificación en acciones
#1886
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Precio por acción
$59.03
Capitalización bursátil
$11.23B
Cambio (1 día)
1.50%
Cambio (1 año)
-21.28%
País
US
Comercio The Cooper Companies, Inc. (COO)
Categoría
Healthcare
Ratio P/B de The Cooper Companies, Inc. (COO)
Ratio P/B al October 2026 TTM: 1.27
Según los informes financieros más recientes y el precio de las acciones de The Cooper Companies, Inc., el ratio P/B actual (TTM) es 1.27. Al final de 2024, el ratio P/B era 2.58.
Historial del ratio P/B de The Cooper Companies, Inc. desde 2000 hasta 2026
Ratio P/B al final de cada año
| Año | Ratio P/B | Cambiar |
|---|---|---|
| 2026 (TTM) | 1.27 | -25.04% |
| 2025 | 1.70 | -34.11% |
| 2024 | 2.58 | 26.03% |
| 2023 | 2.04 | 8.79% |
| 2022 | 1.88 | 150.76% |
| 2021 | 0.75 | -26.84% |
| 2020 | 1.02 | 3.59% |
| 2019 | 0.99 | 3.11% |
| 2018 | 0.96 | 3.67% |
| 2017 | 0.92 | 16.80% |
| 2016 | 0.79 | 14.34% |
| 2015 | 0.69 | -9.62% |
| 2014 | 0.77 | 17.34% |
| 2013 | 0.65 | 24.52% |
| 2012 | 0.52 | 25.01% |
| 2011 | 0.42 | 23.97% |
| 2010 | 0.34 | 64.83% |
| 2009 | 0.21 | 56.96% |
| 2008 | 0.13 | -59.33% |
| 2007 | 0.32 | -30.90% |
| 2006 | 0.47 | -16.55% |
| 2005 | 0.56 | -46.28% |
| 2004 | 1.04 | 29.21% |
| 2003 | 0.80 | 23.52% |
| 2002 | 0.65 | -6.36% |
| 2001 | 0.69 | 8.68% |
| 2000 | 0.64 | 0.00% |
Ratio P/B de empresas similares o competidoras
| Empresa | Ratio P/B | Diferencia del ratio P/B | País |
|---|---|---|---|
| 8.1997 | 543.42% |
US
|
|
| 1.7417 | 36.67% |
FR
|
|
| - | - |
JP
|
|
| 2.1258 | 66.81% |
US
|
|
| - | - |
CH
|
